120 related articles for article (PubMed ID: 6651612)
1. Combined therapy of niacin, colestipol, and fat-controlled diet in men with coronary bypass. Effect on blood lipids and apolipoproteins.
Nessim SA; Chin HP; Alaupovic P; Blankenhorn DH
Arteriosclerosis; 1983; 3(6):568-73. PubMed ID: 6651612
[TBL] [Abstract][Full Text] [Related]
2. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
Brown G; Albers JJ; Fisher LD; Schaefer SM; Lin JT; Kaplan C; Zhao XQ; Bisson BD; Fitzpatrick VF; Dodge HT
N Engl J Med; 1990 Nov; 323(19):1289-98. PubMed ID: 2215615
[TBL] [Abstract][Full Text] [Related]
3. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.
Malloy MJ; Kane JP; Kunitake ST; Tun P
Ann Intern Med; 1987 Nov; 107(5):616-23. PubMed ID: 3662275
[TBL] [Abstract][Full Text] [Related]
4. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
Hunninghake DB; Bell C; Olson L
Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
[TBL] [Abstract][Full Text] [Related]
5. Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia.
Illingworth DR; Phillipson BE; Rapp JH; Connor WE
Lancet; 1981 Feb; 1(8215):296-8. PubMed ID: 6109940
[TBL] [Abstract][Full Text] [Related]
6. Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia.
Kłosiewicz-Latoszek L; Nowicka G; Szostak WB; Naruszewicz M
Atherosclerosis; 1987 Feb; 63(2-3):203-9. PubMed ID: 3827981
[TBL] [Abstract][Full Text] [Related]
7. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
[TBL] [Abstract][Full Text] [Related]
8. Use of niacin, statins, and resins in patients with combined hyperlipidemia.
Brown BG; Zambon A; Poulin D; Rocha A; Maher VM; Davis JW; Albers JJ; Brunzell JD
Am J Cardiol; 1998 Feb; 81(4A):52B-59B. PubMed ID: 9526815
[TBL] [Abstract][Full Text] [Related]
9. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
Weisweiler P
Metabolism; 1989 Mar; 38(3):271-4. PubMed ID: 2918846
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.
Zambon A; Hokanson JE; Brown BG; Brunzell JD
Circulation; 1999 Apr; 99(15):1959-64. PubMed ID: 10208998
[TBL] [Abstract][Full Text] [Related]
11. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
Kane JP; Malloy MJ; Tun P; Phillips NR; Freedman DD; Williams ML; Rowe JS; Havel RJ
N Engl J Med; 1981 Jan; 304(5):251-8. PubMed ID: 7003391
[TBL] [Abstract][Full Text] [Related]
12. The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients.
Insull W; Davidson MH; Demke DM; Dujovne CA; Eckert SM; Ginsberg D; Goldberg AC; Hodis HN; Hughes TA; Kane JP
Atherosclerosis; 1995 Jan; 112(2):223-35. PubMed ID: 7772081
[TBL] [Abstract][Full Text] [Related]
13. Probucol with colestipol in the treatment of hypercholesterolemia.
Dujovne CA; Krehbiel P; Decoursey S; Jackson B; Chernoff SB; Pitterman A; Garty M
Ann Intern Med; 1984 Apr; 100(4):477-82. PubMed ID: 6367578
[TBL] [Abstract][Full Text] [Related]
14. Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
Kuo PT; Hayase K; Kostis JB; Moreyra AE
Circulation; 1979 Feb; 59(2):199-211. PubMed ID: 215338
[TBL] [Abstract][Full Text] [Related]
15. Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia.
Weisweiler P; Merk W; Jacob B; Schwandt P
Eur J Clin Pharmacol; 1986; 30(2):191-4. PubMed ID: 3709644
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
Kuo PT; Wilson AC; Kostis JB; Moreyra AE
Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177
[TBL] [Abstract][Full Text] [Related]
17. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
[TBL] [Abstract][Full Text] [Related]
18. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia.
Groot PH; Dijkhuis-Stoffelsma R; Grose WF; Ambagtsheer JJ; Fernandes J
Acta Paediatr Scand; 1983 Jan; 72(1):81-5. PubMed ID: 6407278
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.
Vega GL; East C; Grundy SM
Arteriosclerosis; 1989; 9(1 Suppl):I135-44. PubMed ID: 2912427
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.
Cashin-Hemphill L; Mack WJ; Pogoda JM; Sanmarco ME; Azen SP; Blankenhorn DH
JAMA; 1990 Dec; 264(23):3013-7. PubMed ID: 2243429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
